Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Herr, S. AlAlwani, R. Eschmann, C. Beißwenger, R. Bals (Homburg, Marburg, Germany). The antimicrobial peptide CRAMP protects against emphysema. Eur Respir J 2012; 40: Suppl. 56, 3741

Member's Comments

No comment yet.

Related content which might interest you: The endogenous antibiotic CRAMP is induced during pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 555s Year: 2004 Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum Source: Eur Respir J 2007; 29: 624-632 Year: 2007 The antimicrobial molecule elafin protects the lung against Staphylococcus aureus infection Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 The antimicrobial peptide LL-37 modulates inflammatory reaction and amplifies ROS of human neutrophils Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Antimicrobial peptides and airway bacterial colonization in bronchiectasis Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies Year: 2018 Lung injury and apoptosis in COPD: Effect of a recombinant anti-protease derived from trappin-2 Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Induction of cathelicidin (LL-37) in rhinovirus-induced COPD exacerbations Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 The human cathelicidin LL37 and mitochondrial DAMPs induce airway inflammation in epithelial cells and mice Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Antimicrobial peptides in induced sputum of asthmatic patients Source: Eur Respir J 2005; 26: Suppl. 49, 484s Year: 2005 The antimicrobial peptide CRAMP is a regulator of inflammation during pneumonia Source: Annual Congress 2006 - Immunology of the airways Year: 2006 Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence Source: ERS Research Seminar 2015 Year: 2015 Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence Source: Eur Respir J 2015; 46: 771-782 Year: 2015 Synthetic peptide gamma-D-Glutaminyl-L-Tryptophan has antituberculosis activity in murine model Source: Eur Respir J 2001; 18: Suppl. 33, 340s Year: 2001 Azithromycin protects bronchial epithelial integrity after Pseudomonas aeruginosa infection independent of bactericidal activity Source: Annual Congress 2008 - Best of lung epithelial cells 2008 Year: 2008 The antimicrobial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands Source: Eur Respir J 2006; 28: Suppl. 50, 582s Year: 2006 The anti-inflammatory effects of helminth-derived peptides in a model of endotoxin-induced acute lung injury Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 The role of antimicrobial peptides in cystic fibrosis in childhood. Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Ghrelin protects against bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 The possible role of gastrin-releasing peptide on pulmonary fibrosis Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Increase of extracellular IL-17A and anti-microbial peptides in the peripheral airways of smokers Source: Annual Congress 2011 - COPD: human studies Year: 2011